Cart
sales@molnova.com
IRAK4-IN-8
CAS No. 2033070-97-0
IRAK4-IN-8( —— )
Catalog No. M35718 CAS No. 2033070-97-0
IRAK4-IN-8 (VI-177) is an IRAK4 inhibitor used to study diseases related to cancer and inflammation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 1319 | Get Quote |
|
| 5MG | 1682 | Get Quote |
|
| 10MG | 2271 | Get Quote |
|
| 25MG | 3266 | Get Quote |
|
| 50MG | 4398 | Get Quote |
|
| 100MG | 5823 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIRAK4-IN-8
-
NoteResearch use only, not for human use.
-
Brief DescriptionIRAK4-IN-8 (VI-177) is an IRAK4 inhibitor used to study diseases related to cancer and inflammation.
-
DescriptionIRAK4-IN-8 (VI-177) is a potent IRAK4 inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetIRAK
-
RecptorIRAK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2033070-97-0
-
Formula Weight499.54
-
Molecular FormulaC23H23F2N7O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(C(=O)C=1N=C(SC1)C=2C=NNC2)C=3C(=NN(C3)[C@@H]4CC[C@H](OCC)CC4)C5=C(F)C=CC(F)=N5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Vanessa Taylor, et al. Compounds and method for treating cytokine release syndrome. WO2021026451A1.
molnova catalog
related products
-
CA-4948
CA-4948 (AU-4948) is a novel potent, selective, orally bioavailable IRAK4 inhibitor.
-
IRAK-1-4 Inhibitor I
IRAK-1-4 Inhibitor I is a potent, dual inhibitor of IRAK4 and IRAK1 with IC50 of 0.2 uM and 0.3 uM, respectively.
-
PF-06650833
PF-06650833 (PF06650833) is a potent and selective IRAK4 inhibitor with IC50 of 0.2 nM.
